{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:18:49Z","timestamp":1792682329968,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T00:00:00Z","timestamp":1658188800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016650","name":"Rare Diseases Clinical Research Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016650","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001491","name":"Belgian American Educational Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ymgmr.2022.100901","type":"journal-article","created":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T18:18:51Z","timestamp":1658773131000},"page":"100901","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Acetazolamide treatment in late onset CDG type 1 due to biallelic pathogenic DHDDS variants"],"prefix":"10.1016","volume":"32","author":[{"given":"Jehan","family":"Mousa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa","family":"Veres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anab","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diederik","family":"De Graef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Morava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ymgmr.2022.100901_bb0005","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.ajhg.2021.09.012","article-title":"Active site variants in STT3A cause a dominant type I congenital disorder of glycosylation with neuromusculoskeletal findings","volume":"108","author":"Wilson","year":"2021","journal-title":"Am. J. Hum. Genet."},{"issue":"6","key":"10.1016\/j.ymgmr.2022.100901_bb0010","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/jimd.12290","article-title":"Predominant and novel de novo variants in 29 individuals with ALG13 deficiency: clinical description, biomarker status, biochemical analysis, and treatment suggestions","volume":"43","author":"Ng","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"issue":"24","key":"10.1016\/j.ymgmr.2022.100901_bb0015","doi-asserted-by":"crossref","first-page":"477","DOI":"10.21037\/atm.2018.10.45","article-title":"Congenital disorders of glycosylation","volume":"6","author":"Chang","year":"2018","journal-title":"Ann. Transl. Med."},{"issue":"1","key":"10.1016\/j.ymgmr.2022.100901_bb0020","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/jimd.12024","article-title":"International clinical guidelines for the management of phosphomannomutase 2-congenital disorders of glycosylation: diagnosis, treatment and follow up","volume":"42","author":"Altassan","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.ymgmr.2022.100901_bb0025","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/bjo.2008.145359","article-title":"Ophthalmological abnormalities in children with congenital disorders of glycosylation type I","volume":"93","author":"Morava","year":"2009","journal-title":"Br. J. Ophthalmol."},{"issue":"11","key":"10.1016\/j.ymgmr.2022.100901_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/genes12111658","article-title":"Genotype-phenotype correlations in PMM2-CDG","volume":"12","author":"Vaes","year":"2021","journal-title":"Genes (Basel)"},{"issue":"1","key":"10.1016\/j.ymgmr.2022.100901_bb0035","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ajhg.2009.06.006","article-title":"Deficiency of Dol-P-Man synthase subunit DPM3 bridges the congenital disorders of glycosylation with the dystroglycanopathies","volume":"85","author":"Lefeber","year":"2009","journal-title":"Am. J. Hum. Genet."},{"issue":"6","key":"10.1016\/j.ymgmr.2022.100901_bb0040","doi-asserted-by":"crossref","first-page":"101198","DOI":"10.1016\/j.isci.2020.101198","article-title":"Retinal degeneration caused by rod-specific Dhdds ablation occurs without concomitant inhibition of protein N-glycosylation","volume":"23","author":"Ramachandra Rao","year":"2020","journal-title":"iScience"},{"issue":"2","key":"10.1016\/j.ymgmr.2022.100901_bb0045","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ajhg.2011.01.001","article-title":"Whole-exome sequencing links a variant in DHDDS to retinitis pigmentosa","volume":"88","author":"Z\u00fcchner","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgmr.2022.100901_bb0050","article-title":"De novo DHDDS variants cause a neurodevelopmental and neurodegenerative disorder with myoclonus","author":"Galosi","year":"2021","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.ymgmr.2022.100901_bb0055","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.tig.2018.03.002","article-title":"Perspectives on glycosylation and its congenital disorders","volume":"34","author":"Ng","year":"2018","journal-title":"Trends Genet."},{"issue":"5","key":"10.1016\/j.ymgmr.2022.100901_bb0060","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.ajhg.2017.09.008","article-title":"High rate of recurrent De Novo mutations in developmental and epileptic encephalopathies","volume":"101","author":"Hamdan","year":"2017","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.ymgmr.2022.100901_bb0065","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13023-016-0468-1","article-title":"A case of fatal Type I congenital disorders of glycosylation (CDG I) associated with low dehydrodolichol diphosphate synthase (DHDDS) activity","volume":"11","author":"Sabry","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"issue":"6","key":"10.1016\/j.ymgmr.2022.100901_bb0070","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/S0002-9440(10)64830-4","article-title":"Reduced heparan sulfate accumulation in enterocytes contributes to protein-losing enteropathy in a congenital disorder of glycosylation","volume":"157","author":"Westphal","year":"2000","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.ymgmr.2022.100901_bb0075","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s10545-011-9301-0","article-title":"From glycosylation disorders to dolichol biosynthesis defects: a new class of metabolic diseases","volume":"34","author":"Cantagrel","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"issue":"34","key":"10.1016\/j.ymgmr.2022.100901_bb0080","doi-asserted-by":"crossref","first-page":"20794","DOI":"10.1073\/pnas.2008381117","article-title":"Structural elucidation of the cis-prenyltransferase NgBR\/DHDDS complex reveals insights in regulation of protein glycosylation","volume":"117","author":"Edani","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.ymgmr.2022.100901_bb0085","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ajhg.2011.01.002","article-title":"A missense mutation in DHDDS, encoding dehydrodolichyl diphosphate synthase, is associated with autosomal-recessive retinitis pigmentosa in Ashkenazi Jews","volume":"88","author":"Zelinger","year":"2011","journal-title":"Am. J. Hum. Genet."},{"issue":"5","key":"10.1016\/j.ymgmr.2022.100901_bb0090","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/ana.25457","article-title":"AZATAX: acetazolamide safety and efficacy in cerebellar syndrome in PMM2 congenital disorder of glycosylation (PMM2-CDG)","volume":"85","author":"Mart\u00ednez-Monseny","year":"2019","journal-title":"Ann. Neurol."},{"issue":"10","key":"10.1016\/j.ymgmr.2022.100901_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21103603","article-title":"Clinical and genetic overview of paroxysmal movement disorders and episodic ataxias","volume":"21","author":"Garone","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.ymgmr.2022.100901_fur1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ymgme.2022.04.002","article-title":"Patient-reported outcomes and quality of life in PMM2-CDG","volume":"136","author":"Ligezka","year":"2022","journal-title":"Mol. Genet. Metab."}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426922000611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426922000611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:52:34Z","timestamp":1762001554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426922000611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":20,"alternative-id":["S2214426922000611"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2022.100901","relation":{},"ISSN":["2214-4269"],"issn-type":[{"value":"2214-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acetazolamide treatment in late onset CDG type 1 due to biallelic pathogenic DHDDS variants","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2022.100901","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100901"}}